New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment
Share Article
JUPITER, Fla. (PRWEB)
April 09, 2021
The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information.
The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because they involve very complex and interrelated cellular operations. Advancements will explore how Bexion Pharmaceuticals, Inc. (Bexion) – a clinical stage biotech company– is focused on the discovery and development of life-changing therapies by leveraging a less well-understood, but extremely important cellular orchestrator called the lysosome.